Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Men, 18yrs and older
Histological or cytological confirmation of prostate adenocarcinoma (symptomatic or asymptomatic)
Prior hormonal therapy, and/or no more than 1 prior chemotherapy regimen (including estramustine and/or corticosteroids) for treatment of prostate adenocarcinoma
You may not be if
Prior radiotherapy to bone metastases within 4 weeks prior to screening
any unresolved chronic toxicity greater than CTCAE grade 2 from previous anticancer therapy
Brain metastases or spinal cord compression, unless treated at least 4 weeks before entry, and stable with steroid treatment for 1 week.
Clareo Health | Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer
